Free Trial

Prestige Consumer Healthcare (PBH) Earnings Date, Estimates & Call Transcripts

$63.18
-0.79 (-1.23%)
(As of 05/28/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 1Estimated
Actual EPS
(May. 14)
$1.02 Missed By -$0.12
Consensus EPS
(May. 14)
$1.14
Skip Charts & View Estimated and Actual Earnings Data

PBH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PBH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Prestige Consumer Healthcare Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20244$1.00$1.09$1.04 
Q2 20245$1.06$1.11$1.08 
Q3 20245$1.04$1.13$1.08 
Q4 20245$1.10$1.14$1.13 
FY 202419$4.20$4.47$4.32 
Q1 20253$0.86$1.10$0.94 
Q2 20252$1.09$1.16$1.13 
Q3 20252$1.15$1.16$1.16 
Q4 20252$1.16$1.29$1.23 
FY 20259$4.26$4.71$4.45 
Q1 20261$1.16$1.16$1.16 
Q2 20261$1.19$1.19$1.19 
Q3 20261$1.20$1.20$1.20 
Q4 20261$1.20$1.20$1.20 
FY 20264$4.75$4.75 $4.75

PBH Earnings Date and Information

Prestige Consumer Healthcare last issued its quarterly earnings results on May 14th, 2024. The reported $1.02 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.14 by $0.12. The business earned $277 million during the quarter, compared to analyst estimates of $287.42 million. Its quarterly revenue was down 3.1% compared to the same quarter last year. Prestige Consumer Healthcare has generated $4.17 earnings per share over the last year ($4.17 diluted earnings per share) and currently has a price-to-earnings ratio of 15.2. Earnings for Prestige Consumer Healthcare are expected to grow by 7.48% in the coming year, from $4.41 to $4.74 per share. Prestige Consumer Healthcare has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.

Prestige Consumer Healthcare Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/1/2024
(Estimated)
------- 
5/14/2024Q4 2024$1.14$1.02($0.12)$1.06$287.42 million$277.00 million      
2/8/2024Q4 2023$1.04$1.06+$0.02$1.06$280.25 million$282.74 million      
11/2/2023Q2 2024$1.07$1.07-$1.07$285.13 million$286.32 million
8/3/2023Q2 2023$1.01$1.06+$0.05$1.06$278.79 million$279.31 million      
5/4/2023Q4 2023$1.04$1.07+$0.03$6.97$280.58 million$285.90 million  
2/2/2023Q3 2023$1.01$1.04+$0.03$1.04$273.84 million$275.50 million      
11/3/2022Q2 2023$1.00$1.02+$0.02$1.02$282.93 million$289.27 million
8/4/2022Q1 2023$1.03$1.09+$0.06$1.09$268.19 million$277.06 million
5/5/2022Q4 2022$0.89$0.91+$0.02$0.80$258.25 million$266.94 million    
2/3/2022Q3 2022$0.89$0.99+$0.10$0.99$260.39 million$274.40 million    
11/4/2021Q3 2021$0.99$1.02+$0.03$1.15$261.23 million$276.23 million    
8/5/2021Q2 2021$0.87$1.14+$0.27$1.14$232.41 million$269.10 million    
5/6/2021Q1 2021$0.78$0.79+$0.01$0.88$230.59 million$237.80 million  
2/3/2021Q4 2020$0.77$0.81+$0.04$0.81$231.55 million$238.80 million    
11/5/2020Q3 2020$0.72$0.78+$0.06$0.68$227.43 million$237.42 million    
8/6/2020Q2 2020$0.70$0.86+$0.16$0.86$221.27 million$229.40 million    
5/7/2020Q1 2020$0.74$0.82+$0.08$0.91$239.65 million$251.20 million    
2/6/2020Q3 2020$0.75$0.81+$0.06$0.87$240.34 million$241.60 million    
10/31/2019Q2 2020$0.66$0.68+$0.02$0.71$237.17 million$238.07 million    
8/1/2019Q1 2020$0.64$0.65+$0.01$0.65$231.52 million$232.15 million    

Prestige Consumer Healthcare Earnings - Frequently Asked Questions

When is Prestige Consumer Healthcare's earnings date?

Prestige Consumer Healthcare has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on PBH's earnings history.

Did Prestige Consumer Healthcare beat their earnings estimates last quarter?

In the previous quarter, Prestige Consumer Healthcare (NYSE:PBH) missed the analysts' consensus estimate of $1.14 by $0.12 with a reported earnings per share (EPS) of $1.02. Learn more on analysts' earnings estimate vs. PBH's actual earnings.

How can I listen to Prestige Consumer Healthcare's earnings conference call?

The conference call for Prestige Consumer Healthcare's latest earnings report can be listened to online. Listen to Conference Call

How can I read Prestige Consumer Healthcare's conference call transcript?

The conference call transcript for Prestige Consumer Healthcare's latest earnings report can be read online. Read Transcript

How can I view Prestige Consumer Healthcare's earnings report?

Prestige Consumer Healthcare's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Prestige Consumer Healthcare generate each year?

Prestige Consumer Healthcare (NYSE:PBH) has a recorded annual revenue of $1.13 billion.

How much profit does Prestige Consumer Healthcare generate each year?

Prestige Consumer Healthcare (NYSE:PBH) has a recorded net income of $209.34 million. PBH has generated $4.17 earnings per share over the last four quarters.

What is Prestige Consumer Healthcare's price-to-earnings ratio?

Prestige Consumer Healthcare (NYSE:PBH) has a trailing price-to-earnings ratio of 15.15 and a forward price-to-earnings ratio of 14.33. The price/earnings-to-growth ratio is 1.81.

What is Prestige Consumer Healthcare's EPS forecast for next year?

Prestige Consumer Healthcare's earnings are expected to grow from $4.41 per share to $4.74 per share in the next year, which is a 7.48% increase.


More Earnings Resources from MarketBeat

This page (NYSE:PBH) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners